Patients’ Preference Between DPP4i and SGLT2i for Type 2 Diabetes Treatment: A Cross-Sectional Evaluation

José Esteban Costa Gil,1 Juan Carlos Garnica Cuéllar,2 Paula Perez Terns,3 Aldo Ferreira-Hermosillo,4 José Antonio Cetina Canto,5 Ángel Alfonso Garduño Perez,2 Pedro Mendoza Martínez,6 Lucas Rista,7 Alejandro Sosa-Caballero,6 Estefanía Vázquez-Mendez,8 Luis Fernando Tejado Gallegos,8 Hungta Chen,9 A...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Costa Gil JE, Garnica Cuéllar JC, Perez Terns P, Ferreira-Hermosillo A, Cetina Canto JA, Garduño Perez ÁA, Mendoza Martínez P, Rista L, Sosa-Caballero A, Vázquez-Mendez E, Tejado Gallegos LF, Chen H, Elizalde A, Tomatis VB
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Dove Medical Press 2022-05-01
Cyfres:	Patient Preference and Adherence
Pynciau:	dipeptidyl peptidase-4 inhibitors patient preference sodium-glucose cotransporter-2 inhibitors type 2 diabetes.
Mynediad Ar-lein:	https://www.dovepress.com/patients-preference-between-dpp4i-and-sglt2i-for-type-2-diabetes-treat-peer-reviewed-fulltext-article-PPA
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!